nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP9—blood—hematologic cancer	0.0281	0.181	CbGeAlD
Vildagliptin—DPP9—lung—hematologic cancer	0.0246	0.159	CbGeAlD
Vildagliptin—DPP9—testis—hematologic cancer	0.0232	0.15	CbGeAlD
Vildagliptin—DPP9—lymph node—hematologic cancer	0.0168	0.109	CbGeAlD
Vildagliptin—DPP4—hematopoietic system—hematologic cancer	0.0162	0.105	CbGeAlD
Vildagliptin—DPP4—blood—hematologic cancer	0.0107	0.0694	CbGeAlD
Vildagliptin—DPP4—bone marrow—hematologic cancer	0.0104	0.0671	CbGeAlD
Vildagliptin—DPP4—lung—hematologic cancer	0.00941	0.0608	CbGeAlD
Vildagliptin—DPP4—testis—hematologic cancer	0.00888	0.0574	CbGeAlD
Vildagliptin—DPP4—lymph node—hematologic cancer	0.00643	0.0416	CbGeAlD
Vildagliptin—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	0.00045	0.000532	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vincristine—hematologic cancer	0.00045	0.000532	CcSEcCtD
Vildagliptin—Fatigue—Vincristine—hematologic cancer	0.000449	0.000531	CcSEcCtD
Vildagliptin—Asthenia—Bleomycin—hematologic cancer	0.000448	0.00053	CcSEcCtD
Vildagliptin—Skin disorder—Cisplatin—hematologic cancer	0.000447	0.000529	CcSEcCtD
Vildagliptin—Dizziness—Hydroxyurea—hematologic cancer	0.000446	0.000528	CcSEcCtD
Vildagliptin—Constipation—Vincristine—hematologic cancer	0.000445	0.000527	CcSEcCtD
Vildagliptin—Hyperhidrosis—Cisplatin—hematologic cancer	0.000445	0.000527	CcSEcCtD
Vildagliptin—Liver function test abnormal—Epirubicin—hematologic cancer	0.000444	0.000525	CcSEcCtD
Vildagliptin—Angiopathy—Dexamethasone—hematologic cancer	0.000443	0.000524	CcSEcCtD
Vildagliptin—Angiopathy—Betamethasone—hematologic cancer	0.000443	0.000524	CcSEcCtD
Vildagliptin—Asthenia—Vinorelbine—hematologic cancer	0.000441	0.000522	CcSEcCtD
Vildagliptin—Nausea—Vinblastine—hematologic cancer	0.00044	0.00052	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000438	0.000518	CcSEcCtD
Vildagliptin—Fatigue—Mitoxantrone—hematologic cancer	0.000437	0.000517	CcSEcCtD
Vildagliptin—Fatigue—Irinotecan—hematologic cancer	0.000437	0.000517	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	0.000437	0.000517	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—hematologic cancer	0.000436	0.000515	CcSEcCtD
Vildagliptin—Constipation—Irinotecan—hematologic cancer	0.000434	0.000513	CcSEcCtD
Vildagliptin—Constipation—Mitoxantrone—hematologic cancer	0.000434	0.000513	CcSEcCtD
Vildagliptin—Diarrhoea—Bortezomib—hematologic cancer	0.000431	0.00051	CcSEcCtD
Vildagliptin—Nasopharyngitis—Epirubicin—hematologic cancer	0.00043	0.000509	CcSEcCtD
Vildagliptin—Urticaria—Alitretinoin—hematologic cancer	0.000429	0.000508	CcSEcCtD
Vildagliptin—Headache—Lenalidomide—hematologic cancer	0.000429	0.000507	CcSEcCtD
Vildagliptin—Angioedema—Triamcinolone—hematologic cancer	0.000428	0.000507	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000426	0.000505	CcSEcCtD
Vildagliptin—Fatigue—Gemcitabine—hematologic cancer	0.000426	0.000504	CcSEcCtD
Vildagliptin—Urticaria—Ifosfamide—hematologic cancer	0.000424	0.000502	CcSEcCtD
Vildagliptin—Headache—Hydroxyurea—hematologic cancer	0.000423	0.0005	CcSEcCtD
Vildagliptin—Constipation—Gemcitabine—hematologic cancer	0.000422	0.0005	CcSEcCtD
Vildagliptin—Asthenia—Thiotepa—hematologic cancer	0.000421	0.000498	CcSEcCtD
Vildagliptin—Diarrhoea—Vinorelbine—hematologic cancer	0.000421	0.000498	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000419	0.000496	CcSEcCtD
Vildagliptin—Infection—Etoposide—hematologic cancer	0.000419	0.000496	CcSEcCtD
Vildagliptin—Connective tissue disorder—Prednisone—hematologic cancer	0.000418	0.000495	CcSEcCtD
Vildagliptin—Nausea—Melphalan—hematologic cancer	0.000418	0.000495	CcSEcCtD
Vildagliptin—Dizziness—Bortezomib—hematologic cancer	0.000416	0.000493	CcSEcCtD
Vildagliptin—Oedema—Prednisolone—hematologic cancer	0.000416	0.000492	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—hematologic cancer	0.000413	0.000489	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—hematologic cancer	0.000411	0.000486	CcSEcCtD
Vildagliptin—Skin disorder—Etoposide—hematologic cancer	0.00041	0.000485	CcSEcCtD
Vildagliptin—Hyperhidrosis—Etoposide—hematologic cancer	0.000408	0.000482	CcSEcCtD
Vildagliptin—Pancreatitis—Epirubicin—hematologic cancer	0.000408	0.000482	CcSEcCtD
Vildagliptin—Asthenia—Thalidomide—hematologic cancer	0.000408	0.000482	CcSEcCtD
Vildagliptin—Dizziness—Vinorelbine—hematologic cancer	0.000407	0.000481	CcSEcCtD
Vildagliptin—Nausea—Lenalidomide—hematologic cancer	0.000406	0.000481	CcSEcCtD
Vildagliptin—Urticaria—Mitoxantrone—hematologic cancer	0.000403	0.000477	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisolone—hematologic cancer	0.000402	0.000476	CcSEcCtD
Vildagliptin—Diarrhoea—Thiotepa—hematologic cancer	0.000402	0.000475	CcSEcCtD
Vildagliptin—Nausea—Hydroxyurea—hematologic cancer	0.000401	0.000474	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—hematologic cancer	0.000398	0.000471	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000398	0.00047	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—hematologic cancer	0.000396	0.000469	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—hematologic cancer	0.000396	0.000469	CcSEcCtD
Vildagliptin—Headache—Bortezomib—hematologic cancer	0.000395	0.000467	CcSEcCtD
Vildagliptin—Asthenia—Carmustine—hematologic cancer	0.000391	0.000463	CcSEcCtD
Vildagliptin—Angioedema—Betamethasone—hematologic cancer	0.000389	0.00046	CcSEcCtD
Vildagliptin—Angioedema—Dexamethasone—hematologic cancer	0.000389	0.00046	CcSEcCtD
Vildagliptin—Diarrhoea—Thalidomide—hematologic cancer	0.000389	0.00046	CcSEcCtD
Vildagliptin—Dizziness—Thiotepa—hematologic cancer	0.000388	0.000459	CcSEcCtD
Vildagliptin—Asthenia—Alitretinoin—hematologic cancer	0.000388	0.000459	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.000386	0.000457	CcSEcCtD
Vildagliptin—Angiopathy—Prednisone—hematologic cancer	0.000386	0.000457	CcSEcCtD
Vildagliptin—Headache—Vinorelbine—hematologic cancer	0.000385	0.000456	CcSEcCtD
Vildagliptin—Asthenia—Ifosfamide—hematologic cancer	0.000383	0.000453	CcSEcCtD
Vildagliptin—Oedema—Triamcinolone—hematologic cancer	0.000383	0.000453	CcSEcCtD
Vildagliptin—Infection—Triamcinolone—hematologic cancer	0.00038	0.00045	CcSEcCtD
Vildagliptin—Weight increased—Epirubicin—hematologic cancer	0.000378	0.000448	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—hematologic cancer	0.000377	0.000446	CcSEcCtD
Vildagliptin—Dizziness—Thalidomide—hematologic cancer	0.000376	0.000444	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—hematologic cancer	0.000375	0.000443	CcSEcCtD
Vildagliptin—Nausea—Bortezomib—hematologic cancer	0.000374	0.000443	CcSEcCtD
Vildagliptin—Asthenia—Vincristine—hematologic cancer	0.000374	0.000442	CcSEcCtD
Vildagliptin—Diarrhoea—Carmustine—hematologic cancer	0.000373	0.000442	CcSEcCtD
Vildagliptin—Nausea—Bleomycin—hematologic cancer	0.000371	0.000439	CcSEcCtD
Vildagliptin—Infestation—Epirubicin—hematologic cancer	0.000371	0.000439	CcSEcCtD
Vildagliptin—Infestation NOS—Epirubicin—hematologic cancer	0.000371	0.000439	CcSEcCtD
Vildagliptin—Malnutrition—Prednisone—hematologic cancer	0.00037	0.000438	CcSEcCtD
Vildagliptin—Hyperhidrosis—Triamcinolone—hematologic cancer	0.00037	0.000438	CcSEcCtD
Vildagliptin—Diarrhoea—Alitretinoin—hematologic cancer	0.00037	0.000437	CcSEcCtD
Vildagliptin—Headache—Thiotepa—hematologic cancer	0.000368	0.000435	CcSEcCtD
Vildagliptin—Diarrhoea—Ifosfamide—hematologic cancer	0.000365	0.000432	CcSEcCtD
Vildagliptin—Nausea—Vinorelbine—hematologic cancer	0.000365	0.000432	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000364	0.000431	CcSEcCtD
Vildagliptin—Asthenia—Irinotecan—hematologic cancer	0.000364	0.00043	CcSEcCtD
Vildagliptin—Asthenia—Mitoxantrone—hematologic cancer	0.000364	0.00043	CcSEcCtD
Vildagliptin—Fatigue—Etoposide—hematologic cancer	0.000364	0.00043	CcSEcCtD
Vildagliptin—Dizziness—Carmustine—hematologic cancer	0.000361	0.000427	CcSEcCtD
Vildagliptin—Constipation—Etoposide—hematologic cancer	0.000361	0.000427	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.000358	0.000423	CcSEcCtD
Vildagliptin—Dizziness—Alitretinoin—hematologic cancer	0.000357	0.000423	CcSEcCtD
Vildagliptin—Diarrhoea—Vincristine—hematologic cancer	0.000356	0.000421	CcSEcCtD
Vildagliptin—Headache—Thalidomide—hematologic cancer	0.000356	0.000421	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—hematologic cancer	0.000356	0.000421	CcSEcCtD
Vildagliptin—Asthenia—Gemcitabine—hematologic cancer	0.000354	0.000419	CcSEcCtD
Vildagliptin—Dizziness—Ifosfamide—hematologic cancer	0.000353	0.000418	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Epirubicin—hematologic cancer	0.000351	0.000415	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—hematologic cancer	0.00035	0.000414	CcSEcCtD
Vildagliptin—Nausea—Thiotepa—hematologic cancer	0.000349	0.000413	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000349	0.000412	CcSEcCtD
Vildagliptin—Oedema—Dexamethasone—hematologic cancer	0.000347	0.000411	CcSEcCtD
Vildagliptin—Oedema—Betamethasone—hematologic cancer	0.000347	0.000411	CcSEcCtD
Vildagliptin—Diarrhoea—Mitoxantrone—hematologic cancer	0.000347	0.00041	CcSEcCtD
Vildagliptin—Diarrhoea—Irinotecan—hematologic cancer	0.000347	0.00041	CcSEcCtD
Vildagliptin—Infection—Dexamethasone—hematologic cancer	0.000345	0.000408	CcSEcCtD
Vildagliptin—Infection—Betamethasone—hematologic cancer	0.000345	0.000408	CcSEcCtD
Vildagliptin—Dizziness—Vincristine—hematologic cancer	0.000344	0.000407	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—hematologic cancer	0.000343	0.000406	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—hematologic cancer	0.000343	0.000406	CcSEcCtD
Vildagliptin—Headache—Carmustine—hematologic cancer	0.000342	0.000404	CcSEcCtD
Vildagliptin—Nervous system disorder—Betamethasone—hematologic cancer	0.00034	0.000403	CcSEcCtD
Vildagliptin—Nervous system disorder—Dexamethasone—hematologic cancer	0.00034	0.000403	CcSEcCtD
Vildagliptin—Headache—Alitretinoin—hematologic cancer	0.000339	0.0004	CcSEcCtD
Vildagliptin—Angioedema—Prednisone—hematologic cancer	0.000338	0.0004	CcSEcCtD
Vildagliptin—Diarrhoea—Gemcitabine—hematologic cancer	0.000338	0.0004	CcSEcCtD
Vildagliptin—Nausea—Thalidomide—hematologic cancer	0.000337	0.000399	CcSEcCtD
Vildagliptin—Hyperhidrosis—Betamethasone—hematologic cancer	0.000336	0.000397	CcSEcCtD
Vildagliptin—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000336	0.000397	CcSEcCtD
Vildagliptin—Dizziness—Irinotecan—hematologic cancer	0.000335	0.000397	CcSEcCtD
Vildagliptin—Urticaria—Etoposide—hematologic cancer	0.000335	0.000396	CcSEcCtD
Vildagliptin—Hepatitis—Epirubicin—hematologic cancer	0.000333	0.000394	CcSEcCtD
Vildagliptin—Urticaria—Prednisolone—hematologic cancer	0.000331	0.000391	CcSEcCtD
Vildagliptin—Asthenia—Cisplatin—hematologic cancer	0.00033	0.000391	CcSEcCtD
Vildagliptin—Fatigue—Triamcinolone—hematologic cancer	0.00033	0.00039	CcSEcCtD
Vildagliptin—Oedema peripheral—Epirubicin—hematologic cancer	0.000328	0.000388	CcSEcCtD
Vildagliptin—Connective tissue disorder—Epirubicin—hematologic cancer	0.000327	0.000387	CcSEcCtD
Vildagliptin—Headache—Vincristine—hematologic cancer	0.000326	0.000386	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—hematologic cancer	0.000324	0.000384	CcSEcCtD
Vildagliptin—Nausea—Carmustine—hematologic cancer	0.000324	0.000383	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—hematologic cancer	0.000323	0.000382	CcSEcCtD
Vildagliptin—Nausea—Alitretinoin—hematologic cancer	0.000321	0.00038	CcSEcCtD
Vildagliptin—Chills—Methotrexate—hematologic cancer	0.000319	0.000377	CcSEcCtD
Vildagliptin—Headache—Irinotecan—hematologic cancer	0.000318	0.000376	CcSEcCtD
Vildagliptin—Headache—Mitoxantrone—hematologic cancer	0.000318	0.000376	CcSEcCtD
Vildagliptin—Nausea—Ifosfamide—hematologic cancer	0.000317	0.000375	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000316	0.000374	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000316	0.000374	CcSEcCtD
Vildagliptin—Arthralgia—Prednisone—hematologic cancer	0.000315	0.000373	CcSEcCtD
Vildagliptin—Diarrhoea—Cisplatin—hematologic cancer	0.000315	0.000373	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000313	0.000371	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—hematologic cancer	0.00031	0.000366	CcSEcCtD
Vildagliptin—Headache—Gemcitabine—hematologic cancer	0.000309	0.000366	CcSEcCtD
Vildagliptin—Nausea—Vincristine—hematologic cancer	0.000309	0.000366	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—hematologic cancer	0.000308	0.000364	CcSEcCtD
Vildagliptin—Urticaria—Triamcinolone—hematologic cancer	0.000304	0.00036	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—hematologic cancer	0.000303	0.000359	CcSEcCtD
Vildagliptin—Asthenia—Etoposide—hematologic cancer	0.000303	0.000358	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000303	0.000358	CcSEcCtD
Vildagliptin—Oedema—Prednisone—hematologic cancer	0.000302	0.000358	CcSEcCtD
Vildagliptin—Angiopathy—Epirubicin—hematologic cancer	0.000302	0.000357	CcSEcCtD
Vildagliptin—Nausea—Irinotecan—hematologic cancer	0.000301	0.000356	CcSEcCtD
Vildagliptin—Nausea—Mitoxantrone—hematologic cancer	0.000301	0.000356	CcSEcCtD
Vildagliptin—Infection—Prednisone—hematologic cancer	0.0003	0.000355	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.0003	0.000355	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.0003	0.000355	CcSEcCtD
Vildagliptin—Fatigue—Dexamethasone—hematologic cancer	0.000299	0.000354	CcSEcCtD
Vildagliptin—Fatigue—Betamethasone—hematologic cancer	0.000299	0.000354	CcSEcCtD
Vildagliptin—Chills—Epirubicin—hematologic cancer	0.000299	0.000353	CcSEcCtD
Vildagliptin—Nervous system disorder—Prednisone—hematologic cancer	0.000296	0.000351	CcSEcCtD
Vildagliptin—Skin disorder—Prednisone—hematologic cancer	0.000294	0.000347	CcSEcCtD
Vildagliptin—Nausea—Gemcitabine—hematologic cancer	0.000293	0.000347	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisone—hematologic cancer	0.000292	0.000346	CcSEcCtD
Vildagliptin—Malnutrition—Epirubicin—hematologic cancer	0.00029	0.000343	CcSEcCtD
Vildagliptin—Diarrhoea—Etoposide—hematologic cancer	0.000289	0.000341	CcSEcCtD
Vildagliptin—Flatulence—Epirubicin—hematologic cancer	0.000285	0.000338	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—hematologic cancer	0.000279	0.000331	CcSEcCtD
Vildagliptin—Dizziness—Etoposide—hematologic cancer	0.000279	0.00033	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—hematologic cancer	0.000276	0.000327	CcSEcCtD
Vildagliptin—Urticaria—Betamethasone—hematologic cancer	0.000276	0.000326	CcSEcCtD
Vildagliptin—Urticaria—Dexamethasone—hematologic cancer	0.000276	0.000326	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000275	0.000326	CcSEcCtD
Vildagliptin—Dizziness—Prednisolone—hematologic cancer	0.000275	0.000325	CcSEcCtD
Vildagliptin—Asthenia—Triamcinolone—hematologic cancer	0.000275	0.000325	CcSEcCtD
Vildagliptin—Nausea—Cisplatin—hematologic cancer	0.000273	0.000324	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—hematologic cancer	0.000268	0.000317	CcSEcCtD
Vildagliptin—Headache—Etoposide—hematologic cancer	0.000264	0.000313	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—hematologic cancer	0.000264	0.000312	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—hematologic cancer	0.000264	0.000312	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000262	0.00031	CcSEcCtD
Vildagliptin—Fatigue—Prednisone—hematologic cancer	0.000261	0.000308	CcSEcCtD
Vildagliptin—Headache—Prednisolone—hematologic cancer	0.000261	0.000308	CcSEcCtD
Vildagliptin—Constipation—Prednisone—hematologic cancer	0.000259	0.000306	CcSEcCtD
Vildagliptin—Dizziness—Triamcinolone—hematologic cancer	0.000253	0.000299	CcSEcCtD
Vildagliptin—Infection—Methotrexate—hematologic cancer	0.000251	0.000297	CcSEcCtD
Vildagliptin—Nausea—Etoposide—hematologic cancer	0.000251	0.000296	CcSEcCtD
Vildagliptin—Asthenia—Betamethasone—hematologic cancer	0.000249	0.000295	CcSEcCtD
Vildagliptin—Asthenia—Dexamethasone—hematologic cancer	0.000249	0.000295	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—hematologic cancer	0.000248	0.000293	CcSEcCtD
Vildagliptin—Nausea—Prednisolone—hematologic cancer	0.000247	0.000292	CcSEcCtD
Vildagliptin—Arthralgia—Epirubicin—hematologic cancer	0.000247	0.000292	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—hematologic cancer	0.000245	0.00029	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000245	0.00029	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—hematologic cancer	0.000244	0.000289	CcSEcCtD
Vildagliptin—Urticaria—Prednisone—hematologic cancer	0.00024	0.000284	CcSEcCtD
Vildagliptin—Headache—Triamcinolone—hematologic cancer	0.00024	0.000284	CcSEcCtD
Vildagliptin—Diarrhoea—Betamethasone—hematologic cancer	0.000238	0.000281	CcSEcCtD
Vildagliptin—Diarrhoea—Dexamethasone—hematologic cancer	0.000238	0.000281	CcSEcCtD
Vildagliptin—Oedema—Epirubicin—hematologic cancer	0.000236	0.00028	CcSEcCtD
Vildagliptin—Infection—Epirubicin—hematologic cancer	0.000235	0.000278	CcSEcCtD
Vildagliptin—Nervous system disorder—Epirubicin—hematologic cancer	0.000232	0.000274	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.00023	0.000272	CcSEcCtD
Vildagliptin—Skin disorder—Epirubicin—hematologic cancer	0.00023	0.000272	CcSEcCtD
Vildagliptin—Dizziness—Betamethasone—hematologic cancer	0.00023	0.000272	CcSEcCtD
Vildagliptin—Dizziness—Dexamethasone—hematologic cancer	0.00023	0.000272	CcSEcCtD
Vildagliptin—Hyperhidrosis—Epirubicin—hematologic cancer	0.000229	0.00027	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—hematologic cancer	0.000228	0.00027	CcSEcCtD
Vildagliptin—Nausea—Triamcinolone—hematologic cancer	0.000227	0.000269	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000227	0.000268	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—hematologic cancer	0.000219	0.000259	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000218	0.000258	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—hematologic cancer	0.000218	0.000258	CcSEcCtD
Vildagliptin—Headache—Betamethasone—hematologic cancer	0.000217	0.000257	CcSEcCtD
Vildagliptin—Headache—Dexamethasone—hematologic cancer	0.000217	0.000257	CcSEcCtD
Vildagliptin—Infection—Doxorubicin—hematologic cancer	0.000217	0.000257	CcSEcCtD
Vildagliptin—Asthenia—Prednisone—hematologic cancer	0.000217	0.000257	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000215	0.000255	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—hematologic cancer	0.000215	0.000254	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—hematologic cancer	0.000213	0.000251	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000212	0.00025	CcSEcCtD
Vildagliptin—Diarrhoea—Prednisone—hematologic cancer	0.000207	0.000245	CcSEcCtD
Vildagliptin—Nausea—Dexamethasone—hematologic cancer	0.000206	0.000244	CcSEcCtD
Vildagliptin—Nausea—Betamethasone—hematologic cancer	0.000206	0.000244	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000204	0.000241	CcSEcCtD
Vildagliptin—Fatigue—Epirubicin—hematologic cancer	0.000204	0.000241	CcSEcCtD
Vildagliptin—Constipation—Epirubicin—hematologic cancer	0.000202	0.000239	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—hematologic cancer	0.000201	0.000237	CcSEcCtD
Vildagliptin—Dizziness—Prednisone—hematologic cancer	0.0002	0.000237	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000199	0.000236	CcSEcCtD
Vildagliptin—Headache—Prednisone—hematologic cancer	0.000189	0.000224	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000189	0.000223	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—hematologic cancer	0.000189	0.000223	CcSEcCtD
Vildagliptin—Urticaria—Epirubicin—hematologic cancer	0.000188	0.000222	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—hematologic cancer	0.000187	0.000221	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—hematologic cancer	0.000181	0.000214	CcSEcCtD
Vildagliptin—Nausea—Prednisone—hematologic cancer	0.00018	0.000212	CcSEcCtD
Vildagliptin—Urticaria—Doxorubicin—hematologic cancer	0.000174	0.000206	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—hematologic cancer	0.000173	0.000205	CcSEcCtD
Vildagliptin—Asthenia—Epirubicin—hematologic cancer	0.00017	0.000201	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—hematologic cancer	0.000167	0.000198	CcSEcCtD
Vildagliptin—Diarrhoea—Epirubicin—hematologic cancer	0.000162	0.000191	CcSEcCtD
Vildagliptin—Headache—Methotrexate—hematologic cancer	0.000158	0.000187	CcSEcCtD
Vildagliptin—Asthenia—Doxorubicin—hematologic cancer	0.000157	0.000186	CcSEcCtD
Vildagliptin—Dizziness—Epirubicin—hematologic cancer	0.000156	0.000185	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—hematologic cancer	0.00015	0.000178	CcSEcCtD
Vildagliptin—Diarrhoea—Doxorubicin—hematologic cancer	0.00015	0.000177	CcSEcCtD
Vildagliptin—Headache—Epirubicin—hematologic cancer	0.000148	0.000175	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—hematologic cancer	0.000145	0.000171	CcSEcCtD
Vildagliptin—Nausea—Epirubicin—hematologic cancer	0.00014	0.000166	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—hematologic cancer	0.000137	0.000162	CcSEcCtD
Vildagliptin—Nausea—Doxorubicin—hematologic cancer	0.00013	0.000154	CcSEcCtD
